Ventriculoperitoneal Shunt Tap 

  • Author: Vamsi Krishna Chinthapalli, MBBS, MRCP, MRCS; Chief Editor: Cristian Gragnaniello, MD   more...
 
Updated: Feb 17, 2012
 

Overview

Ventriculoperitoneal (VP) shunts, which are used to treat hydrocephalus, shunt cerebrospinal fluid (CSF) from the lateral ventricles of the brain into the peritoneum. Tapping or aspirating the shunt is performed for both diagnostic reasons (eg, evaluate for shunt infection and blockage) and therapeutic reasons (eg, allows fluids to be drawn off to alleviate symptoms from a blocked shunt).

The ventricles of the brain are a communicating network of cavities filled with CSF and located within the brain parenchyma. The ventricular system is composed of 2 lateral ventricles, the third ventricle, the cerebral aqueduct, and the fourth ventricle. The choroid plexuses located in the ventricles produce CSF, which fills the ventricles and subarachnoid space, following a cycle of constant production and reabsorption. For more information about the relevant anatomy, see Ventricles of the Brain.

The exact role of shunt taps in diagnosing shunt malfunctions is still under debate;[1] therefore, the patient's neurosurgeon should be consulted before this procedure is carried out. The nonspecialist should be aware of this procedure, as it can be lifesaving.[2]

Next

Indications

Diagnostic

  • Suspected ventriculoperitoneal (VP) shunt infection or meningitis
  • Suspected VP shunt blockage

Therapeutic

  • Severely raised intracranial pressure in the presence of a VP shunt
Previous
Next

Contraindications

Absolute

  • Infection over the entry site

Relative

  • Coagulopathy
  • Lack of shunt imaging or information

Because shunt aspiration removes cerebrospinal fluid (CSF) from the supratentorial compartment, increased intracranial pressure is not a contraindication.

Previous
Next

Anesthesia

  • Local anesthesia is generally not necessary; many practitioners believe that the act of infiltrating the skin and subcutaneous tissue with local anesthetic is more painful than the shunt aspiration itself.
  • However, in young children, topical local anesthetic cream prior to the procedure may be useful. For more information, see Topical Anesthesia.
Previous
Next

Equipment

An image of the equipment needed is shown in the image below.

  • Sterile gloves
  • Povidone-iodine (Betadine) or chlorhexidine (Hibiclens) solution
  • Sterile fenestrated drape
  • Syringe, 3-5 mL
  • Butterfly needles, 23 or 25 gauge (ga)
  • Three-way stopcock
  • Cerebrospinal fluid (CSF) manometer
  • Gauze swabs
  • Wound dressing
  • Numbered specimen tubes for CSF (3-4)Equipment needed for a ventriculoperitoneal (VP) sEquipment needed for a ventriculoperitoneal (VP) shunt tap.
Previous
Next

Positioning

  • The patient should be supine with the head oriented so that the ventriculoperitoneal (VP) shunt reservoir lies uppermost.
  • The reservoir is usually located on the right side of the head and feels like a smooth dome under the skin.
Previous
Next

Technique

  • Except in the presence of immediately life-threatening indications, a neurosurgeon (preferably the one who placed the shunt) should be consulted before a ventriculoperitoneal shunt is tapped.
  • Explain the procedure, benefits, risks, and complications to the patient, patient’s representative, or both.
  • Obtain informed consent in accordance with hospital protocol.
  • Review the shunt series imaging or previous imaging to locate the shunt reservoir.
  • If hair overlies the reservoir, parting and gelling the hair away from the shunt, as shown below, is often enough. Otherwise, the area around the reservoir can be shaved with a razor. In children, this should be avoided, if possible. Scalp preparation for tap. Scalp preparation for tap.
  • Clean the skin with an antiseptic (eg, povidone-iodine) solution. Circle outward from the entry site or radially with each swab.
  • Apply a sterile fenestrated drape over the reservoir site as shown below. Fenestrated drape applied to patient. Fenestrated drape applied to patient.
  • Insert a small (23 ga or smaller) butterfly needle perpendicular to the skin into the reservoir, as shown below. Once entered, a drop in resistance is felt. Advance slowly until the bevel of the needle is fully inside the reservoir;[3] then, hold the needle securely as the cerebrospinal fluid (CSF) enters the tubing. Shunt tap with syringe attached. Shunt tap with syringe attached.
  • If flow is poor, slightly adjust the angle of the needle or alter the needle's depth. Note that poor flow is strongly correlated with proximal shunt obstruction.[4, 5]
  • Measure the opening pressure using a manometer (shown below). If no manometer is available, the tubing of the butterfly needle can suffice. It is measured vertically from the top of the CSF column to the level of the reservoir or to the level of the tragus of the ear. State which landmark was used in the record. Cerebrospinal fluid (CSF) manometer attached to tuCerebrospinal fluid (CSF) manometer attached to tubing for opening pressure reading.
  • Slowly collect 5 mL of CSF into separate containers for analysis, as depicted below. Collection of CSF samples. Collection of CSF samples.
  • Withdraw the needle from the reservoir and apply gentle pressure over the entry site with gauze, as shown in the image below, for at least 2 minutes. Gauze applied to site of shunt tap. Gauze applied to site of shunt tap.
  • Send the CSF sample for cell count, protein level, glucose level, Gram stain, and culture.[6] A paired blood glucose level sample should also be taken. CSF samples. CSF samples.
Previous
Next

Pearls

  • Strict aseptic technique is essential in this procedure, as the consequence of introducing infection is usually replacement of the whole shunt.
  • Allow the cerebrospinal fluid (CSF) to drip into the tubes through the end of the needle or 3-way tap.
  • Aspiration can result in the choroid plexus being sucked up into the shunt tip, precipitating shunt blockage. This is especially true in slit ventricles.
  • A shunt tap should only be considered after performing a CT or MRI scan of the brain and shunt series imaging. Other common infections should also be excluded, since shunt infections are unlikely more than 3 months after placement.
  • Manometry and documentation of the flow rate is important.[7] High opening CSF pressures (>25 cm H2 O above the level of the ventricle) are associated with distal shunt obstruction in approximately 90% of cases.[5] Poor flow is associated with proximal shunt obstruction in over 90% of cases.[4, 5]
Previous
Next

Complications

  • Infection: The risk of introducing infection from a tap is very low.[2] However, the consequences can mean shunt revision. Infection is mostly due to skin flora entering the shunt, and the most common organism responsible is Staphylococcus epidermidis. An aseptic technique is important to avoid this.
  • Bleeding: A small risk exists of bleeding from subcutaneous vessels during the tap. Using a small butterfly needle and checking for coagulopathy before the procedure minimizes this risk.
  • Cerebrospinal fluid (CSF) leak from puncture site: Using a small needle and applying pressure after the procedure can help prevent this complication.
  • Ventricular collapse: Rapid aspiration of CSF from a shunt can lead to collapse of the ventricles, especially in slit ventricles. Collapse can, in turn, precipitate shunt blockage, as choroid plexus may be aspirated into the proximal tip of the shunt. It can also cause rupture of bridging veins to the brain parenchyma, creating a subdural hematoma. These are rare complications.
  • Misplaced tap: Unfamiliarity with the shunt type can mean that the wrong section of tubing is punctured or that components adjacent to the reservoir have been damaged by the needle. Even with a butterfly needle, the possibility of serious trauma such as an intracranial hemorrhage exists.[3] This highlights the importance of correct localization and familiarity.
Previous
 
Contributor Information and Disclosures
Author

Vamsi Krishna Chinthapalli, MBBS, MRCP, MRCS  Specialty Registrar in Neurology, National Hospital for Neurology and Neurosurgery, UK

Disclosure: Nothing to disclose.

Coauthor(s)

Laurence D Watkins, MBChB, MA, FRCS  Consultant Neurosurgeon, National Hospital for Neurology and Neurosurgery, UK

Disclosure: Medtronic Honoraria Speaking and teaching; B Braun None Some research activity within my department are supported by B Braun; Integra None Review panel membership; Boston Scientific None Named on patent

Specialty Editor Board

Andrew K Chang, MD  Associate Professor, Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center

Andrew K Chang, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

Cristian Gragnaniello, MD  Fellow in Spinal Neurosurgery, Department of Neurosurgery, Australian School of Advanced Medicine, Macquarie University, Australia

Cristian Gragnaniello, MD is a member of the following medical societies: American Association of Neurological Surgeons and Congress of Neurological Surgeons

Disclosure: Nothing to disclose.

References
  1. Miller JP, Fulop SC, Dashti SR, Robinson S, Cohen AR. Rethinking the indications for the ventriculoperitoneal shunt tap. J Neurosurg Pediatrics. Jun 2008;1(6):435-8. [Medline]. [Full Text].

  2. Noetzel MJ, Baker RP. Shunt fluid examination: risks and benefits in the evaluation of shunt malfunction and infection. J Neurosurg. Aug 1984;61(2):328-32. [Medline].

  3. Maartens NF, Aurora P, Richards PG. An unusual complication of tapping a ventriculoperitoneal shunt. Eur J Paediatr Neurol. 2000;4(3):125-9. [Medline]. [Full Text].

  4. Sood S, Kim S, Ham SD, Canady AI, Greninger N. Useful components of the shunt tap test for evaluation of shunt malfunction. Childs Nerv Syst. Jun 1993;9(3):157-61; discussion 162. [Medline].

  5. Rocque BG, Lapsiwala S, Iskandar BJ. Ventricular shunt tap as a predictor of proximal shunt malfunction in children: a prospective study. J Neurosurg Pediatrics. Jun 2008;1(6):439-43. [Medline].

  6. Bayston R, Leung TS, Wilkins BM, Hodges B. Bacteriological examination of removed cerebrospinal fluid shunts. J Clin Pathol. Sep 1983;36(9):987-90. [Medline]. [Full Text].

  7. Watkins L, Hayward R, Andar U, Harkness W. The diagnosis of blocked cerebrospinal fluid shunts: a prospective study of referral to a paediatric neurosurgical unit. Childs Nerv Syst. Mar 1994;10(2):87-90. [Medline].

  8. Scribano PV, Pool S, Smally AJ. Comparison of ventriculoperitoneal shunt tap and lumbar puncture in a child with meningitis. Pediatr Emerg Care. Aug 2002;18(4):E1-3. [Medline]. [Full Text].

Previous
Next
 
Equipment needed for a ventriculoperitoneal (VP) shunt tap.
Scalp preparation for tap.
Fenestrated drape applied to patient.
Shunt tap with syringe attached.
Cerebrospinal fluid (CSF) manometer attached to tubing for opening pressure reading.
Collection of CSF samples.
Gauze applied to site of shunt tap.
CSF samples.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.